<VariationArchive VariationID="860051" VariationName="NM_001282225.2(ADA2):c.1397_1403del (p.Lys466fs)" VariationType="Deletion" Accession="VCV000860051" Version="12" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-02-20" DateCreated="2020-04-15" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="849009" VariationID="860051">
      <GeneList>
        <Gene Symbol="ADA2" FullName="adenosine deaminase 2" GeneID="51816" HGNC_ID="HGNC:1839" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>22q11.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="17178790" stop="17221848" display_start="17178790" display_stop="17221848" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="17660191" stop="17690778" display_start="17660191" display_stop="17690778" Strand="-" />
          </Location>
          <OMIM>607575</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001282225.2(ADA2):c.1397_1403del (p.Lys466fs)</Name>
      <CanonicalSPDI>NC_000022.11:17181858:TCAGCCTTCA:TCA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>22q11.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="17181859" stop="17181865" display_start="17181859" display_stop="17181865" variantLength="7" positionVCF="17181858" referenceAlleleVCF="GTCAGCCT" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="17662749" stop="17662755" display_start="17662749" display_stop="17662755" variantLength="7" positionVCF="17662748" referenceAlleleVCF="GTCAGCCT" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>K346fs</ProteinChange>
      <ProteinChange>K466fs</ProteinChange>
      <ProteinChange>K225fs</ProteinChange>
      <ProteinChange>K424fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001282225.1" sequenceAccession="NM_001282225" sequenceVersion="1" change="c.1397_1403delAGGCTGA">
            <Expression>NM_001282225.1:c.1397_1403delAGGCTGA</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000022.10" sequenceAccession="NC_000022" sequenceVersion="10" change="g.17662752_17662758del" Assembly="GRCh37">
            <Expression>NC_000022.10:g.17662752_17662758del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000022.11" sequenceAccession="NC_000022" sequenceVersion="11" change="g.17181862_17181868del" Assembly="GRCh38">
            <Expression>NC_000022.11:g.17181862_17181868del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033943.1" sequenceAccession="NG_033943" sequenceVersion="1" change="g.44990_44996del">
            <Expression>NG_033943.1:g.44990_44996del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001282225.2" sequenceAccession="NM_001282225" sequenceVersion="2" change="c.1397_1403del" MANESelect="true">
            <Expression>NM_001282225.2:c.1397_1403del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001269154.1" sequenceAccession="NP_001269154" sequenceVersion="1" change="p.Lys466fs">
            <Expression>NP_001269154.1:p.Lys466fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001282226.2" sequenceAccession="NM_001282226" sequenceVersion="2" change="c.1397_1403del">
            <Expression>NM_001282226.2:c.1397_1403del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001269155.1" sequenceAccession="NP_001269155" sequenceVersion="1" change="p.Lys466fs">
            <Expression>NP_001269155.1:p.Lys466fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001282227.2" sequenceAccession="NM_001282227" sequenceVersion="2" change="c.1271_1277del">
            <Expression>NM_001282227.2:c.1271_1277del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001269156.1" sequenceAccession="NP_001269156" sequenceVersion="1" change="p.Lys424fs">
            <Expression>NP_001269156.1:p.Lys424fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001282228.2" sequenceAccession="NM_001282228" sequenceVersion="2" change="c.1271_1277del">
            <Expression>NM_001282228.2:c.1271_1277del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001269157.1" sequenceAccession="NP_001269157" sequenceVersion="1" change="p.Lys424fs">
            <Expression>NP_001269157.1:p.Lys424fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001282229.2" sequenceAccession="NM_001282229" sequenceVersion="2" change="c.1037_1043del">
            <Expression>NM_001282229.2:c.1037_1043del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001269158.1" sequenceAccession="NP_001269158" sequenceVersion="1" change="p.Lys346fs">
            <Expression>NP_001269158.1:p.Lys346fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_177405.3" sequenceAccession="NM_177405" sequenceVersion="3" change="c.674_680del">
            <Expression>NM_177405.3:c.674_680del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_803124.1" sequenceAccession="NP_803124" sequenceVersion="1" change="p.Lys225fs">
            <Expression>NP_803124.1:p.Lys225fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1217" sequenceAccession="LRG_1217">
            <Expression>LRG_1217:g.44990_44996del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1217t1" sequenceAccession="LRG_1217t1">
            <Expression>LRG_1217t1:c.1397_1403del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1217p1" sequenceAccession="LRG_1217p1" change="p.Lys466fs">
            <Expression>LRG_1217p1:p.Lys466fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="754904956" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001282225.2(ADA2):c.1397_1403del (p.Lys466fs) AND Vasculitis due to ADA2 deficiency" Accession="RCV001066294" Version="7">
        <ClassifiedConditionList TraitSetID="13385">
          <ClassifiedCondition DB="MedGen" ID="C3887654">Vasculitis due to ADA2 deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-07-05" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001282225.2(ADA2):c.1397_1403del (p.Lys466fs) AND Autoinflammatory syndrome" Accession="RCV002264175" Version="3">
        <ClassifiedConditionList TraitSetID="53109">
          <ClassifiedCondition DB="MedGen" ID="C3890737">Autoinflammatory syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2016-12-12" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001282225.2(ADA2):c.1397_1403del (p.Lys466fs) AND not provided" Accession="RCV003151275" Version="2">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2022-07-21" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-07-05" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2020-04-15" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">30503522</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31945408</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32888943</ID>
        </Citation>
        <DescriptionHistory Dated="2023-02-02">
          <Description>Conflicting classifications of pathogenicity</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-08-22">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-08-07">
          <Description>Conflicting classifications of pathogenicity</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-07-09">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="53109" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="43795" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Autoinflammatory syndrome</ElementValue>
                <XRef ID="MONDO:0019751" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="19234" />
                <XRef ID="19234" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="93665" DB="Orphanet" />
              <XRef ID="C3890737" DB="MedGen" />
              <XRef ID="MONDO:0019751" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="13385" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6159" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Vasculitis due to ADA2 deficiency</ElementValue>
                <XRef ID="MONDO:0014306" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">VASCULITIS, AUTOINFLAMMATION, IMMUNODEFICIENCY, AND HEMATOLOGIC DEFECTS SYNDROME</ElementValue>
                <XRef Type="MIM" ID="615688" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607575.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607575.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607575.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607575.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607575.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607575.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607575.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607575.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607575.0009" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Polyarteritis nodosa, childhoood-onset</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">VAIHS</ElementValue>
                <XRef Type="MIM" ID="615688" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12383" />
                <XRef ID="12383" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Adenosine deaminase 2 deficiency (DADA2) is a complex systemic autoinflammatory disorder in which vasculopathy/vasculitis, dysregulated immune function, and/or hematologic abnormalities may predominate. Inflammatory features include intermittent fevers, rash (often livedo racemosa/reticularis), and musculoskeletal involvement (myalgia/arthralgia, arthritis, myositis). Vasculitis, which usually begins before age ten years, may manifest as early-onset ischemic (lacunar) and/or hemorrhagic strokes, or as cutaneous or systemic polyarteritis nodosa. Hypertension and hepatosplenomegaly are often found. More severe involvement may lead to progressive central neurologic deficits (dysarthria, ataxia, cranial nerve palsies, cognitive impairment) or to ischemic injury to the kidney, intestine, and/or digits. Dysregulation of immune function can lead to immunodeficiency or autoimmunity of varying severity; lymphadenopathy may be present and some affected individuals have had lymphoproliferative disease. Hematologic disorders may begin early in life or in late adulthood, and can include lymphopenia, neutropenia, pure red cell aplasia, thrombocytopenia, or pancytopenia. Of note, both interfamilial and intrafamilial phenotypic variability (e.g., in age of onset, frequency and severity of manifestations) can be observed; also, individuals with biallelic ADA2 pathogenic variants may remain asymptomatic until adulthood or may never develop clinical manifestations of DADA2.</Attribute>
                <XRef ID="NBK544951" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">31393689</ID>
                <ID Source="BookShelf">NBK544951</ID>
              </Citation>
              <XRef ID="404553" DB="Orphanet" />
              <XRef ID="C3887654" DB="MedGen" />
              <XRef ID="MONDO:0014306" DB="MONDO" />
              <XRef Type="MIM" ID="615688" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4977700" SubmissionDate="2022-07-07" DateLastUpdated="2022-07-09" DateCreated="2022-07-09">
        <ClinVarSubmissionID localKey="2022-02807|MONDO:0019751" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002543369" DateUpdated="2022-07-09" DateCreated="2022-07-09" Type="SCV" Version="1" SubmitterName="Genome Diagnostics Laboratory, The Hospital for Sick Children" OrgID="1043" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-12-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ADA2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001282225.1:c.1397_1403delAGGCTGA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0019751" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11761158</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7167133" SubmissionDate="2023-03-09" DateLastUpdated="2023-03-18" DateCreated="2023-03-18">
        <ClinVarSubmissionID localKey="NM_001282225.2(ADA2):c.1397_1403del|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003839315" DateUpdated="2023-03-18" DateCreated="2023-03-18" Type="SCV" Version="1" SubmitterName="Genetic Services Laboratory, University of Chicago" OrgID="1238" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-07-21">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>DNA sequence analysis of the ADA2 gene demonstrated a 7 base pair deletion in exon 9, c.1397_1403del. This sequence change results in an amino acid frameshift and creates a premature stop codon one amino acid downstream of the change, p.Lys466Thrfs*2. While this sequence change is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last few amino acid(s) of the ADA2 protein. This sequence change has been described in the homozygous state in one individual with pure red cell aplasia and bone marrow failure and shown to have no ADA2 enzyme activity in vitro (PMID 31945408) and has also been described in three individuals in the homozygous state with Diamond Blackfan Anemia (PMID 30503522) and in one individual with primary immunodeficiency (PMID: 32888943). This sequence change has been described in the gnomAD database in one individual which corresponds to a population frequency of 0.0004% (dbSNP rs754904956). These collective evidences indicate that this sequence change is likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ADA2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001282225.2:c.1397_1403del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12941816</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2396897" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="6411648|MedGen:C3887654" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001231301" DateUpdated="2024-02-20" DateCreated="2020-04-15" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-07-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">30503522</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31945408</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32888943</ID>
          </Citation>
          <Comment>This variant is present in population databases (rs754904956, gnomAD 0.003%). For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the ADA2 protein in which other variant(s) (p.Asn491Lysfs*16) have been determined to be pathogenic (Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. ClinVar contains an entry for this variant (Variation ID: 860051). This variant is also known as 17662748:GTCAGCCT&gt;G. This premature translational stop signal has been observed in individual(s) with bone marrow failure, Diamond-Blackfan anemia, and/or primary immunodeficiency (PMID: 30503522, 31945408, 32888943). This sequence change creates a premature translational stop signal (p.Lys466Thrfs*2) in the ADA2 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 46 amino acid(s) of the ADA2 protein.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ADA2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000022.10:g.17662749_17662755del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3887654" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4977700" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0019751" MappingRef="MONDO">
        <MedGen CUI="C3890737" Name="Autoinflammatory syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7167133" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2396897" TraitType="Disease" MappingType="XRef" MappingValue="C3887654" MappingRef="MedGen">
        <MedGen CUI="C3887654" Name="Vasculitis due to ADA2 deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

